1Preliminary thinking on the establishment of China's future pharmacovigilance systemZHANG Ya-juan, CHEN Hui, YANG Yue2017-20232Updates and amendments of viral vaccines in the Chinese Pharmacopoeia 2020XU Li, GUO Zhong-ping2024-20283Development and challenges of mRNA-based therapeuticsYU Ling-li, LI Xiang-yu, CHEN Gui-liang, HE Wu2029-20334Research on the adaptive licensing pathway for new drug registration in EU and its enlightenment to ChinaWU Di, YANG Li, WEI Yan-yi, CHEN Yu-wen, WANG Zu-guang, YANG Ze-ying2034-20415Analysis of technical opportunities in the field of traditional Chinese medicine antidepressants from the perspective of patentNIE Ze-wen, ZHANG Wen-feng, LI Qian, YUAN Hong-mei2042-20486Ubrogepant: an oral new drug against migraineWANG Ya-nan, WEI Wei, HONG Yi2049-20527Consideration on the implementation of ICH M4QLIU Juan, ZHOU Li-ting, YU Hong, HE Wu, ZHANG Ning2053-20588Considerations on clinical value of new traditional Chinese medicines from the view of TCM practiceAN Na, HAN Ling2059-20639Advances in the methods of evaluating male reproductive toxicity in vitroLI Ying-qi, LI Shen-ning, ZHU Hai-mei, XU Han-lin, LI Man-qi, YANG Zi-xuan, QIU Yun-liang, CHANG Yan2064-206810Research progress in application of multi-criteria decision analysis in the field of drug benefit-risk assessmentHUANG Qian-qian, WANG Tao, KANG Qi, CHEN Yang, QU Li-ping, ZOU Wen-jun2069-207411Application of high-throughput miniature bioreactors in biopharmaceuticalsYAO Xiao-yuan, PEI Xin, ZHA Xin-hua, ZHANG Lei, JI Yu2075-208212Overview and applications of master protocol in clinical trialsMAO Yuan-ming, ZHAN Jin-qi, WANG Rong-rong, XIE Qiu-tang, DAI Ying-ying, LIU Shu-wei, ZHOU Jin-yu, ZHU Hong-jia, MA Jing2083-209013Comparison of commonly used evaluation methods of dissolution curves and their advantages and disadvantagesMA Li, ZHU Chuan-yong, HE Xiao-lin, DUAN Xiang-ning, GAO Zhi-chen, Lü Zhao-yun, TAN De-jiang2091-209714Optimization of dry granulation process of Shufeng Jiedu capsules placebo based on the similarity of characteristic attributesGUO Cheng-jie, XIAN Jie-chen, HU Jia-liang, DU Ruo-fei, WU Fei, FENG Yi, LIN Xiao2098-210415Study on the effect of standardized myrtle on Nrf2/HO-1 pathway in chronic obstructive pulmonary disease ratsLIN Qi, LI Zi-ru, GOU Jin-ling, YAN Xiao-ping, ZHENG Wei-nan, LIN Qun-ying2105-211016Evaluation of the performance of one kind of imported nitrofurantoin susceptibility test diskZHANG Ge, HUANG Jing-jing, DUAN Si-meng, ZHANG Jing-jia, ZHAO Ying, XU Chun-ying2111-211517Bibliometric analysis of adverse drug reactions of vemurafenibYIN Yue, QIU Xin-ye, ZHANG Yan-hua2116-2120 